Glazer Capital reported a 5.44% stake in Drugs Made In America Acquisition DMAA · 1,822,952 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 5.44%
Last report: First report
Shares held: 1,822,952 sh
Class: Ordinary Shares
Stock: Drugs Made In America Acquisition DMAA
Holder: Glazer Capital
Event date: 25/03/31
Filed: 25/05/15

First 5%+ report · 5.44% stake

Drugs Made In America Acquisition trades, last 26 weeks

What else happened in Drugs Made In America Acquisition around then

Filed or reported within 30 days of the trade day · 25/03/01~25/04/30

Glazer Capital's other 5% stake reports

Glazer Capital
5% stakeAccelerant Holdings
5% stake
Accelerant Holdings
ARX
5% stake
5,969,101 sh
5% stake
Filed 09/30
Glazer Capital
5% stakeBaldwin Insurance Group
5% stake
Baldwin Insurance Group
BWIN
5.35% stake
5,179,906 sh
5.35% stake
Filed 09/25
Glazer Capital
5% stakeBiolife Solutions
5% stake
Biolife Solutions
BLFS
5.49% stake
2,685,520 sh
5.49% stake
Filed 09/24
Glazer Capital
5% stakeViking Acquisition Corp I
5% stake
Viking Acquisition Corp I
VACI
3.04% stake
720,109 sh
3.04% stake
Filed 08/13
Glazer Capital
5% stakeSuma Acquisition
5% stake
Suma Acquisition
SUMA
6.24% stake
1,103,895 sh
6.24% stake
Filed 08/13